DrugPatentWatch
DrugPatentWatch provides data and analytics on pharmaceutical patents, exclusivity, and generic entry timelines, helping life sciences companies, investors, and legal professionals assess market opportunities and risks around drug patent expirations. The platform aggregates information from regulatory and patent sources to support competitive intelligence, portfolio strategy, and forecasting. It monetizes through subscription access to its online database and related data services.
- Business Intelligence & Dashboards
- Data Integration & ETL
- Revenue
- $1.5M
- Employees
- 10
- Founded
- 2002
- Headquarters
- New York City, United States of America
What 10 Arbolus experts think of DrugPatentWatch
NPS scores for DrugPatentWatch show a range of 6 to 10, with the majority (70%) in the 7-9 range. There is only one Promoter (NPS 10), several Passives, and two Detractors (NPS 6). Renewal intent for high spenders shows uncertainty, with one clear non-renewal and others unsure. Platform stickiness is strong among users with more than one year of implementation (60%), while about 20% are in early stages (less than 1 year). Key themes include moderate to strong satisfaction and extended implementation timelines, but some concerns over renewal intent in higher spend brackets.Overall Customer Sentiment: Neutral
Who reviewed DrugPatentWatch
- C-Suite 70% (7)
- Director 30% (3)
Employer names and spend open once the report publishes.
Tell us when the DrugPatentWatch report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
10 Net Promoter Score, from 10 scored reviews- Promoters 3
- Passives 5
- Detractors 2
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 0%Plan to renew, by seniority
- 0% 2 answers
- 0% 1 answer
- 6.5/10 Average score from undecided customers
- 6/10 Average score from customers not renewing
More in Data & Analytics and Consulting & Professional Services
Other companies in both categories with a customer report.
For people who use DrugPatentWatch
Do you use DrugPatentWatch at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 10 customers of DrugPatentWatch have already contributed
Takes a few minutes. Your identity stays anonymous.